Our Molecular Genetics portfolio provides solutions for all areas of disease, including screening, diagnosis, and monitoring. Through a range of partners, Abacus dx aims to provide Australian and New Zealand laboratories with simple and efficient testing solutions for a range of methods including polymerase chain reaction, next-generation sequencing, and fluorescence in situ hybridisation.
Idylla™ ThyroidPrint® Assay (RUO)* is a novel qPCR-based 10-gene classifier with its signature representing both the tumour microenvironment (CXCR3, CXCL10, CCR3, CCR7, and CXADR) and tumour epithelial cells (TIMP1, CLDN1, KTR19, AFAPL2, and HMOX1).
[…]
Biocartis Idylla™ for colorectal cancer
The Idylla solution is a revolutionary, fully automated, real-time PCR based molecular testing system designed to offer results in a minimum amount of time.
[…]
Introducing the Asuragen AmplideX® Nanopore Carrier Plus Kit* – a revolutionary solution for carrier screening for challenging hard-to-read genes, leveraging long-read sequencing technology to provide unparalleled insights into genetic conditions. Expanded prenatal screening protocols traditionally require multiple methods to […]
Discover the Invivoscribe control portfolio
Invivoscribe offers an extensive range of General Purpose Reagents (GPRs) and Research Use Only (RUO) controls.
[…]
WHEN TIME MATTERS. THINK BIOCARTIS IDYLLA*. YOUR BIOMARKER TEST RESULTS WITHIN 3 HOURS.
The Idylla™ solution is a revolutionary, fully automated, real-time PCR based molecular testing system designed to offer results in a minimum amount of time.
[…]
Abacus dx are thrilled to announce ZytoVision* received their In Vitro Diagnostics Regulation (IVDR) certification for its selected product portfolio.
[…]